Hope For Hepatitis C Patients In Poor Countries – New Affordable Combination With High Cure Rate 12/04/2018 by Intellectual Property Watch Leave a Comment A new affordable combination treatment for hepatitis C patients with a 97 percent cure rate was announced today.
Taiwan IP Office Moves Beyond Politics To Forge Links With Other IP Offices, Enforce IP Rights 10/04/2018 by Catherine Saez, Intellectual Property Watch 1 Comment TAIPEI, Taiwan — The building is impressive. Taiwan’s intellectual property office, located in the Dan-an district of Taipei, deals with patents, trademarks, designs, and utility models. Not being a recognised member of the United Nations, Taiwan cannot access the World Intellectual Property Organization treaties, in particular the Patent Cooperation Treaty. However, Taiwan is dedicated to enforcing IP rights, and entertains agreements with several IP offices in the world, including China, which is Taiwan’s major trading partner.
Special Feature: Blocking Taiwan From Joining WHO Affects Global Health Security, Officials Say 09/04/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment TAIPEI, Taiwan – Two years after the victory of Taiwan Democratic Progressive Party (DPP) and President Tsai Ing-wen, Taiwan is feeling the effects of the DPP’s position against the “One China principle.” At the World Health Organization, China is allegedly successfully blocking Taiwan from participating in the annual World Health Assembly, and in a number of WHO technical meetings, officials say. Beyond the political dimension of the dissent between China and Taiwan, the situation may hurt the Taiwanese and global health security, Taiwanese officials said.
US Imprisons Chinese Scientist For Theft Of Engineered Rice Seeds 04/04/2018 by Intellectual Property Watch Leave a Comment A Chinese scientist has been sentenced to jail for more than 10 years for conspiring to steal samples of a highly developed variety of genetically modified rice seeds from a Kansas biopharmaceutical research facility, the US Justice Department said in a release.
UAEM Students Launch Campaign To Drop Publicly Funded Patent Claim On Cancer Drug In India 16/03/2018 by Intellectual Property Watch 2 Comments The Universities Allied for Essential Medicines (UAEM) this week launched a campaign to ask the University of California to drop its pursuit of a patent on the prostrate cancer drug Xtandi in India in order to make it affordable for patients. Xtandi sells at “exorbitant” rates in the United States, they said, a seeming violation of the licensing guidelines of the publicly funded University of California system which guarantees an “appropriate” return on taxpayer investments.
Japan Patent Office Decides “TE’ CON MIEL” (Tea With Honey) Is Distinctive In Relation To Tea 20/02/2018 by Guest contributor for Intellectual Property Watch Leave a Comment In a recent trademark opposition, the Opposition Board of the Japan Patent Office (JPO) decided to overrule the opposition against TM Registration no. 5951823 for word mark “TÉ CON MIEL” designating tea in class 30 due to distinctiveness of the mark among relevant Japanese consumers.
Indian Pharma Industry Disputes US Industry IP Index 15/02/2018 by William New, Intellectual Property Watch Leave a Comment The United States Chamber of Commerce industry group recently issued its annual global IP index, analysing intellectual property protection in 50 countries, as a prelude to the annual US government list of countries seen as not adequately protection US companies’ IP rights. Now an Indian industry group has issued a counter-statement to the Chamber index, calling it a “tirade” and “self-serving”.
Republic Day Of India Celebration In Geneva: Sounds, Sights, Tastes – And History 30/01/2018 by William New, Intellectual Property Watch 1 Comment Friends and followers of the nation and culture of India gathered in Geneva this week to celebrate India’s Republic Day, with a ceremony and feast held in the halls of the UN World Intellectual Property Organization. Among the many achievements and areas of growth mentioned of the rising economy was its prowess in generic medicines production.
JPO Refused To Register Wordmark “ROMEO GIGLI” Due To Lack Of Consent From Italian Fashion Designer 29/01/2018 by Guest contributor for Intellectual Property Watch Leave a Comment In a recent decision, the Appeal Board of Japan Patent Office (JPO) refused to register trademark application no. 2015- 100245 for a red-colored word mark “ROMEO GIGLI” in gothic script (see below) designating goods of Class 24 and 25 on the grounds that applicant failed to obtain a consent from Italian fashion designer, Romeo Gigli, based on Article 4(1)(viii) of the Trademark Law, writes Masaki Mikami.
Japan Patent Office Invalidates The Word Mark “Bord’or” In Relation To Bordeaux Wines 12/01/2018 by Guest contributor for Intellectual Property Watch 1 Comment In a decision in an invalidation trial jointly claimed by INSTITUT NATIONAL DE L’ORIGINE ET DE LA QUALITE and CONSEIL INTERPROFESSIONNEL DU VIN DE BORDEAUX, the Invalidation Board of Japan Patent Office (JPO) ordered the invalidation of trademark registration no. 5737079 for a word mark “Bord’or” in script fonts (see below) in violation of Article 4(1)(vii) of the Trademark Law, writes Masaki Mikami.
